Chiron Real Estate Inc.
- XRN · NYSE
- Real Estate Investment Trusts
- Bethesda, MD
- 30 employees
- CIK 0001533615
Updated from SEC filings through
Top things to know
Executives
- Mark Okey Decker Jr CEO and President 4, 2026-08-31
- Robert J. Kiernan CFO and Treasurer 4, 2026-08-31
- Danica Holley Chief Administrative Officer 4, 2026-08-31
- Matthew Fitzsimmons Whitlock Chief Investment Officer 4, 2026-08-31
- Aaron Robert Roseth COO 4, 2026-08-31
- Jamie Allen Barber General Counsel and Secretary 4, 2026-08-31
Chiron Real Estate Inc. is a U.S. public company in real estate investment trusts (SIC 6798), headquartered in Bethesda, MD. It trades as XRN on NYSE. Revenue was $148M in the fiscal year ending December 31, 2025, +6.8% from the year before. It reported about 30 employees. Mark Okey Decker Jr is CEO and President.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $148M 10-K, 2026-03-02 | $139M 10-K, 2026-03-02 | $141M 10-K, 2026-03-02 | $137M 10-K, 2025-02-28 | $116M 10-K, 2024-02-28 |
| Operating income | Not on file | Not on file | Not on file | Not on file | Not on file |
| SG&A | $20.0M 10-K, 2026-03-02 | $21.1M 10-K, 2026-03-02 | $16.9M 10-K, 2026-03-02 | $16.5M 10-K, 2025-02-28 | $16.5M 10-K, 2024-02-28 |
| Net income | -$6.9M 10-K, 2026-03-02 | $6.7M 10-K, 2026-03-02 | $21.7M 10-K, 2026-03-02 | $20.0M 10-K, 2025-02-28 | $18.3M 10-K, 2022-03-01 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Mark Okey Decker Jr Chief Executive Officer & Director @ Chiron Real Estate | CEO and President | 4, 2026-08-31 |
| Robert J. Kiernan | CFO and Treasurer | 4, 2026-08-31 |
| Danica Holley | Chief Administrative Officer | 4, 2026-08-31 |
| Matthew Fitzsimmons Whitlock | Chief Investment Officer | 4, 2026-08-31 |
| Aaron Robert Roseth | COO | 4, 2026-08-31 |
| Jamie Allen Barber | General Counsel and Secretary | 4, 2026-08-31 |
| Alfonzo Leon | CIO | 4, 2026-02-25 |
What Chiron Real Estate Inc. does
Chiron Real Estate Inc. (the “Company,” “us,” “we,” or “our”) is a Maryland corporation and internally managed REIT that primarily acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company’s common stock is listed on the New York Stock Exchange. On February 23, 2026, the Company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 13.2 million (as of November 2, 2026) | 10-Q, November 6, 2026 |
|---|---|---|
| Public float | $436M (as of June 30, 2025) | 10-K, March 2, 2026 |
| Reportable segments | 2 (period ending September 30, 2026) | 10-Q, November 6, 2026 |
| Latest proxy statement | Meeting May 20, 2026 (filed April 8, 2026) | DEF 14A, April 8, 2026 |
| Auditor | Deloitte & Touche LLP (McLean, VA) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| August 17, 2026 | Matthew Fitzsimmons Whitlock Chief Investment Officer | Buy | 1,000 | $37K | Form 4, August 17, 2026 |
| August 12, 2026 | Aaron Robert Roseth COO | Buy | 13,500 | $496K | Form 4, August 13, 2026 |
| August 11, 2026 | Mark Okey Decker Jr CEO and President | Buy | 6,875 | $247K | Form 4, August 13, 2026 |
| August 11, 2026 | Mark Okey Decker Jr CEO and President | Buy | 550 | $20K | Form 4, August 13, 2026 |
| August 11, 2026 | Charles Fitzgerald Director | Buy | 14,000 | $501K | Form 4, August 13, 2026 |
| August 10, 2026 | Mark Okey Decker Jr CEO and President | Buy | 8,000 | $287K | Form 4, August 12, 2026 |
| August 10, 2026 | Charles Fitzgerald Director | Buy | 27,600 | $992K | Form 4, August 12, 2026 |
| May 14, 2026 | Matthew Cypher Director | Buy | 1,420 | $50K | Form 4, May 15, 2026 |
Recent 8-K events
- 8-K filed 2026-11-04
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-10-05
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.03 Creation of a direct financial obligation
- 8-K filed 2026-08-05
- Item 2.02 Results of operations and financial condition (earnings release)
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-08-03
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-07-17
- Item 5.02 Departure or appointment of directors or officers; compensation
- 8-K filed 2026-07-06
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-07-02
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- 8-K filed 2026-06-02
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2026-05-20
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-05-08
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
Frequently asked questions about Chiron Real Estate Inc.
- What does Chiron Real Estate Inc. do?
- In its own words, from Item 1 of its 10-K: "Chiron Real Estate Inc. (the “Company,” “us,” “we,” or “our”) is a Maryland corporation and internally managed REIT that primarily acquires healthcare facilities leased to physician groups and regional and national healthcare systems. The Company’s common stock is listed on the New York Stock Exchange. On February 23, 2026, the Company changed its name from Global Medical REIT Inc. to Chiron Real Estate Inc."
- What is Chiron Real Estate Inc.'s revenue?
- $148M for the fiscal year ending December 31, 2025, from its 10-K filed March 2, 2026.
- Is Chiron Real Estate Inc. profitable?
- Chiron Real Estate Inc. reported net income of -$6.9M for the fiscal year ending December 31, 2025.
- How many employees does Chiron Real Estate Inc. have?
- About 30 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Chiron Real Estate Inc.?
- Mark Okey Decker Jr, CEO and President, as named in a 4 filed August 31, 2026.
- Who is the CFO of Chiron Real Estate Inc.?
- Robert J. Kiernan, CFO and Treasurer, as named in a 4 filed August 31, 2026.
- Where is Chiron Real Estate Inc. headquartered?
- Bethesda, MD.
- What is Chiron Real Estate Inc.'s stock ticker?
- XRN, XRN-PA, XRN-PB on NYSE.
- What industry is Chiron Real Estate Inc. in?
- Real Estate Investment Trusts, SIC code 6798.
- What is Chiron Real Estate Inc.'s website?
- chironre.com. Investor relations: https://www.chironre.com/investor/investor-overview/default.aspx.
- When does Chiron Real Estate Inc. report earnings next?
- February 2, 2027. Source: estimate_8k_pattern.
- Is Chiron Real Estate Inc. a public company?
- Yes. Chiron Real Estate Inc. files with the SEC under CIK 0001533615 and trades as XRN.
- Who audits Chiron Real Estate Inc.?
- Deloitte & Touche LLP, McLean, VA, as named in its latest annual report (10-K).
- How many shares of Chiron Real Estate Inc. are outstanding?
- 13.2 million shares as of November 2, 2026, from its 10-Q filed November 6, 2026.
- What is Chiron Real Estate Inc.'s public float?
- $436M as of June 30, 2025, as reported on the cover of its 10-K filed March 2, 2026.
- How many business segments does Chiron Real Estate Inc. report?
- 2 reportable segments for the period ending September 30, 2026, from its 10-Q filed November 6, 2026.
- When is Chiron Real Estate Inc.'s annual shareholder meeting?
- May 20, 2026, per its proxy statement (DEF 14A) filed April 8, 2026.
- Have Chiron Real Estate Inc. insiders traded stock recently?
- Since August 15, 2025, officers and directors reported 1 open-market sale worth about $861K and 21 purchases worth about $4.2M on Forms 4 and 5. The most recent: Matthew Fitzsimmons Whitlock (Chief Investment Officer) bought 1,000 shares on August 17, 2026.